Eli Lilly’s ‘Triple-G’ Drug Tops Ozempic in Head-to-Head Type 2 Diabetes Trial
Topline Section 3 outcomes present Eli Lilly’s retatrutide beat Novo’s Ozempic on measures of blood sugar and weight reduction in ...
Tag: Lillys
Lilly’s Newly Acquired Drug Shows Promise as Next-Gen Blood Cancer Med
An Eli Lilly drug bringing a brand new strategy to blood cancers now has encouraging early knowledge from a small ...
Eli Lilly’s Neuro Prospects Expand to Sleep Science With $6.3B Centessa Acquisition
Centessa Prescription drugs’ cleminorexton is a part of the orexin agonist drug class, which might introduce a brand new method ...
Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop an Oral GLP-1 Drug
The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, ...
Eli Lilly’s stock falls after 2024 guidance misses forecasts
Eli Lilly’s expectations for sales in the fourth quarter of last year missed forecasts, driven by lower-than-expected sales of its ...
Eli Lilly’s obesity drug Zepbound approved to treat sleep apnea in U.S.
The Food and Drug Administration on Friday cleared Eli Lilly’s obesity drug Zepbound as the first treatment for a common ...
Eli Lilly’s Zepbound Leads to Greater Weight Loss vs. Novo Nordisk Drug in Head-to-Head Test
The battle for market share between the two leaders in the booming obesity drug sector has a new data point ...
Discover the latest in health and fitness with Your Health 247. Get expert advice, workout routines, healthy recipes, and mental wellness tips to lead a healthier, happier life. Stay informed and empowered with us!